A Glasgow AI pharma startup has secured £1.5 million to drive growth in the United States. Talking Medicines’s PatientMetRx platform is driven by artificial intelligence models to provide science-based insights which cut through the noise from social platforms. By structuring and translating the patient’s voice into a Patient Confidence Score (PCS), Talking Medicines aims to … Continue reading AI pharma startup Talking Medicines eyes US market